miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.

作者: Yi Xiao , Changliang Su , Taoran Deng

DOI: 10.3892/OL.2016.5115

关键词:

摘要: The expression of microRNA-223 (miR-233) has been investigated in various types cancer. However, to the best our knowledge, and function miR-223 acute myeloid leukemia (AML) remains be elucidated. was measured by reverse transcription-quantitative polymerase chain reaction. Following transfection with miR-223, cell viability assays, apoptosis western blot analysis luciferase assays were conducted AML lines. In present study, it initially observed that downregulated patients compared healthy subjects. It also demonstrated inhibited proliferation enhanced Additionally, study provided evidence may directly target F-box WD repeat domain containing 7 AML. identification candidate genes provide an understanding potential mechanisms underlying development conclusion, results have therapeutic implications exploited for further treatment

参考文章(46)
Alan W Lau, Hidefumi Fukushima, Wenyi Wei, The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis. Frontiers in Bioscience. ,vol. 17, pp. 2197- 2212 ,(2012) , 10.2741/4045
Brian S. White, John F. DiPersio, Genomic tools in acute myeloid leukemia: From the bench to the bedside Cancer. ,vol. 120, pp. 1134- 1144 ,(2014) , 10.1002/CNCR.28552
Nicola Amodio, Marco Rossi, Lavinia Raimondi, Maria Rita Pitari, Cirino Botta, Pierosandro Tagliaferri, Pierfrancesco Tassone, miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies Oncotarget. ,vol. 6, pp. 12837- 12861 ,(2015) , 10.18632/ONCOTARGET.3805
Diamantina Vasilatou, Sotirios Papageorgiou, Vassiliki Pappa, Efstathios Papageorgiou, John Dervenoulas, The role of microRNAs in normal and malignant hematopoiesis. European Journal of Haematology. ,vol. 84, pp. 1- 16 ,(2010) , 10.1111/J.1600-0609.2009.01348.X
F Bacci, E Sabattini, C Sagramoso, S A Pileri, WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. ,vol. 102, pp. 83- 87 ,(2010)
Xiaoying Zhou, Wujuan Jin, Hongyan Jia, Jin Yan, Guoxin Zhang, MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7 Journal of Experimental & Clinical Cancer Research. ,vol. 34, pp. 28- 28 ,(2015) , 10.1186/S13046-015-0145-6
Martin D. Jansson, Anders H. Lund, MicroRNA and cancer Molecular Oncology. ,vol. 6, pp. 590- 610 ,(2012) , 10.1016/J.MOLONC.2012.09.006
Bo-sheng Li, Yong-liang Zhao, Gang Guo, Wei Li, En-dong Zhu, Xiao Luo, Xu-hu Mao, Quan-ming Zou, Pei-wu Yu, Qian-fei Zuo, Na Li, Bin Tang, Kai-yun Liu, Bin Xiao, Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection PLoS ONE. ,vol. 7, pp. e41629- ,(2012) , 10.1371/JOURNAL.PONE.0041629
S P Nana-Sinkam, C M Croce, Clinical Applications for microRNAs in Cancer Clinical Pharmacology & Therapeutics. ,vol. 93, pp. 98- 104 ,(2013) , 10.1038/CLPT.2012.192
Lihui Wu, Huihui Li, Cheng You Jia, Wei Cheng, Mei Yu, Min Peng, Yuanqing Zhu, Qianlei Zhao, Yi Wei Dong, Kang Shao, Anle Wu, Xing Zhong Wu, MicroRNA-223 regulates FOXO1 expression and cell proliferation FEBS Letters. ,vol. 586, pp. 1038- 1043 ,(2012) , 10.1016/J.FEBSLET.2012.02.050